Using RNA therapies to treat Alzheimer's disease
Treating Alzheimer's Disease with PMO RNA Therapeutics
This study is exploring a new type of treatment using RNA technology to help people with Alzheimer's by targeting the root cause of the disease, aiming to reduce harmful proteins in the brain that lead to memory problems.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-11037379 on NIH RePORTER |
What this research studies
This research investigates the potential of RNA therapeutics to target the underlying causes of Alzheimer's disease, specifically focusing on the Amyloid Precursor Protein (APP) and its role in the disease's progression. By utilizing advanced RNA technology, the study aims to develop treatments that can selectively inhibit the production of harmful amyloid-beta peptides, which are responsible for the formation of plaques in the brain. The approach is designed to provide a more effective solution compared to existing therapies that only address symptoms rather than the root cause. Patients may be monitored for changes in cognitive function and overall brain health as part of the treatment process.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with Alzheimer's disease who are experiencing cognitive decline.
Not a fit: Patients with other forms of dementia or those who do not have a diagnosis of Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a groundbreaking treatment that slows or halts the progression of Alzheimer's disease, improving quality of life for patients.
How similar studies have performed: Previous research has shown promise in using RNA therapeutics for various conditions, indicating potential success for this novel approach in treating Alzheimer's disease.
Where this research is happening
La Jolla, United States
- University of California, San Diego — La Jolla, United States (Active)
Researchers
- Principal investigator: Dowdy, Steven F — University of California, San Diego
- Study coordinator: Dowdy, Steven F
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.